Pulse Biosciences (PLSE) Share-based Compensation (2015 - 2026)

Pulse Biosciences has reported Share-based Compensation for 12 years, with the latest figure at $73.9 million in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 446.76% year-over-year to $73.9 million in Q2 2026; TTM through Jun 2026 was $73.9 million, a 446.76% increase from a year earlier, with the FY2025 full-year figure at $29.5 million, up 62.98% from the prior year.
• Share-based Compensation was $73.9 million for Q2 2026 at Pulse Biosciences, up from $5.0 million in the prior quarter.
• The five-year high for Share-based Compensation was $73.9 million in Q2 2026, with the low at $748000.0 in Q4 2022.
• Average Share-based Compensation over 5 years is $12.4 million, with a median of $7.4 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Share-based Compensation sank 79.29% in 2022, then soared 446.76% in 2026.
• Over 5 years, Share-based Compensation stood at $748000.0 in 2022, then surged by 956.54% to $7.9 million in 2023, then declined by 14.04% to $6.8 million in 2024, then fell by 26.84% to $5.0 million in 2025, then jumped by 1386.44% to $73.9 million in 2026.
• The last three Share-based Compensation figures came in at $73.9 million (Q2 2026), $5.0 million (Q4 2025), and $13.3 million (Q3 2025), per Business Quant data.